NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
BIL Vyapar CoC Approves Resolution Plan Request and Evaluation Matrix
BIL Vyapar Limited, formerly known as Binani Industries, has announced the outcomes of its 6th Committee of Creditors (CoC) meeting under the Corporate Insolvency Resolution Process (CIRP). The CoC has officially approved the Request for Resolution Plan (RFRP) and the Evaluation Matrix, which are critical steps for inviting and assessing potential bidders for the company. Additionally, the committee ratified the CIRP costs and the appointment of tax consultants. This progress indicates that the insolvency process is moving toward the stage of seeking a formal resolution plan to settle outstanding debts.
முக்கிய அம்சங்கள்
CoC approved the Request for Resolution Plan (RFRP) and Evaluation Matrix via e-voting concluded on March 23, 2026.The 6th meeting of the Committee of Creditors was held on March 13, 2026, to advance the insolvency roadmap.Ratification of CIRP costs and the appointment of Pawan Vani & Associates as Tax Consultants was finalized.The company remains under the Corporate Insolvency Resolution Process (CIRP) as per SEBI and IBC regulations.
👀 கவனிக்க வேண்டியவை
Investors should remain highly cautious as equity shareholders typically face significant dilution or total loss of value during insolvency resolutions. Monitor the upcoming resolution plans to determine if any value will be preserved for minority shareholders.
Bikaji Foods Subsidiary Acquires Additional 8.59% Stake in Hazelnut Factory for ₹40 Crore
Bikaji Foods Retail Limited (BFRL), a wholly-owned subsidiary of Bikaji Foods International, has completed the second tranche of its acquisition in Hazelnut Factory Food Products Private Limited (THF). This tranche involved acquiring an 8.59% stake for ₹39.99 crore, bringing Bikaji's total aggregate shareholding in THF to 48.99%. THF is a growing F&B brand with a turnover of ₹54.31 crore in FY25, specializing in premium bakery, sweets, and café operations. The move is part of Bikaji's strategic expansion into the Quick Service Restaurant (QSR) and premium food segments.
முக்கிய அம்சங்கள்
Acquired 8.59% additional stake in THF for a cash consideration of ₹39.99 croreTotal aggregate shareholding in THF increased to 48.99% with a total investment of approx. ₹101 croreTHF turnover grew from ₹39.31 crore in FY23 to ₹54.31 crore in FY25Strategic focus on expanding the Quick Service Restaurant (QSR) vertical through a House-of-Brand strategyTHF operates cafés in Uttar Pradesh and Delhi, offering bakery, patisserie, and artisanal sweets
👀 கவனிக்க வேண்டியவை
Investors should monitor the integration of THF into Bikaji's retail portfolio as it represents a shift toward higher-margin premium bakery and QSR segments. The steady growth of THF's turnover suggests a successful brand that could enhance Bikaji's consolidated revenue and market presence.
Birla Corp Commissions 1.4 MT Capacity Expansion at Kundanganj; Total Capacity Reaches 21.4 MT
Birla Corporation's subsidiary, RCCPL, has successfully commissioned a 1.4 million ton (mt) third production line at its Kundanganj unit in Uttar Pradesh. This expansion, completed at an estimated cost of Rs 300 crore, increases the company's total consolidated capacity to 21.4 mt. The project is strategically positioned to serve central and eastern UP and will benefit from GST-linked investment incentives for 12 years. Additionally, the company is integrating a 5-MW solar plant to raise renewable energy consumption to 40% at the unit.
முக்கிய அம்சங்கள்
Commissioned 1.4 mt additional grinding capacity at Kundanganj, UP, for approximately Rs 300 croreTotal consolidated production capacity scaled up to 21.4 mt, with a roadmap to reach 27.6 mt by 2028-29Entitled to GST-linked investment-promotion incentives for a duration of 12 yearsInstalling a 5-MW solar power plant to increase renewable energy share from 30% to 40%Strategic focus on high-growth markets in Uttar Pradesh and increased production of blended cement (PPC)
👀 கவனிக்க வேண்டியவை
Investors should look favorably on this capacity addition as it strengthens Birla Corp's regional leadership and provides fiscal benefits through long-term incentives. The clear roadmap to 27.6 mt capacity by 2028-29 suggests a sustained growth trajectory.
Birla Cable to Merge with Vindhya Telelinks; Share Exchange Ratio Set at 10:115
Birla Cable Limited has approved a scheme of amalgamation with Vindhya Telelinks Limited, which will result in the dissolution of Birla Cable. Shareholders of Birla Cable will receive 10 shares of Vindhya Telelinks for every 115 shares held. The merger consolidates the M.P. Birla Group's cable and EPC businesses, creating a unified entity with a combined 9-month turnover of approximately Rs. 3,118 crore. This strategic move aims to enhance operational efficiency, strengthen the balance sheet for large-scale infrastructure projects, and simplify the corporate structure.
முக்கிய அம்சங்கள்
Share swap ratio: 10 shares of Vindhya Telelinks (FV Rs. 10) for every 115 shares of Birla Cable (FV Rs. 10).Birla Cable reported a 9-month turnover of Rs. 557.01 crore and a net worth of Rs. 229.12 crore as of December 2025.Vindhya Telelinks reported a standalone 9-month turnover of Rs. 2,561.27 crore and a net worth of Rs. 1,335.37 crore.Post-merger, the total share capital of Vindhya Telelinks will expand from 1.18 crore to 1.39 crore shares.Public shareholding in the merged entity (Vindhya Telelinks) will increase to 58.74% from 56.46%.
👀 கவனிக்க வேண்டியவை
Investors should calculate the implied value of Birla Cable based on Vindhya Telelinks' current market price using the 10:115 ratio to identify potential arbitrage. The merger is beneficial for long-term holders as it creates a larger entity with better bidding capacity for capital-intensive infrastructure projects.
SBI Raises Rs 6,051 Crore via Basel III Compliant Tier 2 Bonds at 7.05% Coupon
State Bank of India (SBI) has successfully raised Rs 6,051 crore through the allotment of Basel III compliant Tier 2 bonds. These unsecured, subordinated bonds carry a coupon rate of 7.05% and have a tenure of 10 years. The capital raised will help the bank strengthen its capital adequacy ratio and support its credit growth objectives. The bonds are scheduled for redemption on March 20, 2036, with interest payments made annually.
முக்கிய அம்சங்கள்
Total fundraise of Rs 6,051 crore via Basel III compliant Tier 2 bondsFixed coupon rate of 7.05% per annum with annual interest paymentsInstrument tenure of 10 years with final redemption date of March 20, 2036Bonds issued at a face value of Rs 1 crore each and will be listed on BSE and NSE
👀 கவனிக்க வேண்டியவை
This capital infusion strengthens SBI's balance sheet and provides the necessary headroom for lending expansion. Long-term investors should view this as a positive step in maintaining the bank's capital buffers.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
SBIN Receives Income Tax Demand Notice of ₹6,337.5 Crore for AY 2023-24
State Bank of India (SBIN) has received a significant tax demand notice of ₹6,337.5 crore, including interest, for the Assessment Year 2023-24. The demand follows scrutiny assessment proceedings where the Income Tax Department made disallowances on various grounds. The bank has clarified that it is already involved in litigation on similar grounds for previous years, indicating a recurring dispute. SBIN intends to contest the order before appellate authorities and states that the demand will not impact its current operations.
முக்கிய அம்சங்கள்
Income Tax demand of ₹63,37,52,52,550 (approx. ₹6,337.5 crore) raised for AY 2023-24.The demand includes interest and arises from disallowances made under Section 143(3) of the IT Act.SBIN is already contesting similar tax disallowances from earlier years in various legal forums.The bank plans to file an appeal against the order within the prescribed legal timelines.Management confirms no immediate impact on the bank's operational activities or other business functions.
👀 கவனிக்க வேண்டியவை
Investors should monitor the outcome of the appellate proceedings as the amount is material, though such tax disputes are relatively common for large public sector banks. No immediate action is required as the bank is following standard legal procedures to contest the demand.
Hester Biosciences Credit Rating Downgraded to CARE BBB; Stable by CARE Ratings
CARE Ratings has downgraded Hester Biosciences' long-term bank facilities from 'CARE BBB+; Stable' to 'CARE BBB; Stable' and short-term ratings from 'A2' to 'A3+'. The downgrade follows a review of the company's FY25 audited and 9MFY26 unaudited financial performance. Management has labeled this downgrade as 'transitional,' pointing towards recent improvements in operating margins, ROCE, and debt coverage ratios post-September 2025. The company maintains adequate liquidity for its debt obligations and has recently secured a manufacturing license for the Avian Influenza H9N2 vaccine.
முக்கிய அம்சங்கள்
Long-term bank facilities downgraded to CARE BBB; Stable from CARE BBB+; StableShort-term bank facilities downgraded to CARE A3+ from CARE A2Total bank facilities rated by CARE Ratings amount to ₹131.47 croreManagement reports improved debt coverage indicators in H1FY26 despite the rating actionCompany holds 75% global market share in PPR vaccine and 35% Indian market share in poultry vaccines
👀 கவனிக்க வேண்டியவை
Investors should exercise caution due to the credit downgrade, which may increase future borrowing costs. Monitor upcoming quarterly results to see if the management's claim of a 'transitional' phase reflects in actual bottom-line improvement and debt reduction.
SBI Subsidiary SBI Funds Management Files DRHP for IPO; SBI to Divest 6.3% Stake
State Bank of India's subsidiary, SBI Funds Management Limited (SBIFML), has filed a Draft Red Herring Prospectus (DRHP) for an Initial Public Offering (IPO). The IPO involves a total stake sale of 10.0013%, comprising 203,709,239 equity shares. SBI will sell a 6.3007% stake (128,334,397 shares) through an Offer for Sale (OFS), while its partner Amundi India Holding will sell 3.7006%. This move is a significant value-unlocking event for SBI, as SBIFML is one of India's largest asset management companies.
முக்கிய அம்சங்கள்
SBIFML filed DRHP for an IPO of up to 203,709,239 equity shares representing 10.0013% of its capital.SBI to sell 128,334,397 shares (6.3007% stake) via Offer for Sale (OFS).Amundi India Holding to divest 75,374,842 shares (3.7006% stake) in the same IPO.SBI's share count for the OFS was revised from 3.2 crore to 12.83 crore following a bonus share issuance.The IPO remains subject to regulatory approvals from SEBI and market conditions.
👀 கவனிக்க வேண்டியவை
Investors should maintain a positive outlook on SBI as this IPO will unlock the market value of its AMC business and provide a capital boost. Monitor the final valuation and pricing of the SBIFML IPO to assess the exact impact on SBI's sum-of-the-parts (SOTP) valuation.
One MobiKwik Systems has appointed Anis Pathan as Chief Risk Officer to lead its Enterprise Risk Management framework. The appointment comes as the company scales rapidly, reporting a record Q3FY26 GMV of ₹48,100 crore and a 3.2x year-on-year surge in UPI transactions. Pathan brings 14 years of experience from NSDL Payments Bank and ICICI Lombard to manage risks across the group's new payment aggregation and stock broking licenses. This move aims to strengthen the security and scalability of the platform which currently serves over 186.6 million registered users.
முக்கிய அம்சங்கள்
Appointment of Anis Pathan as CRO to oversee strategic, financial, and cyber risks.Reported record-breaking Q3FY26 GMV of ₹48,100 crore.Achieved a 3.2x year-on-year surge in UPI transaction volumes.Maintains an 18% market share in the PPI wallet gross transaction value as of December 2025.Expansion into new verticals following the acquisition of payment aggregation and stock broking licenses.
👀 கவனிக்க வேண்டியவை
Investors should monitor how the new risk leadership supports the company's transition into stock broking and lending. The strengthening of the management team is a positive sign for long-term regulatory compliance and operational stability.
SBI Raises ₹6,051 Crore via Basel III Compliant Tier 2 Bonds at 7.05% Coupon
State Bank of India (SBI) has successfully raised ₹6,051 crore through the issuance of Basel III compliant Tier 2 bonds. The bonds carry a coupon rate of 7.05% and have a tenure of 10 years, with a call option available after 5 years on March 20, 2031. The bidding process on the NSE EBP platform saw healthy participation with 47 bids received. This capital raise is intended to strengthen the bank's capital adequacy ratio and support its future credit growth.
முக்கிய அம்சங்கள்
Raised ₹6,051 crore through unsecured, subordinated Basel III compliant Tier 2 bondsFixed coupon rate of 7.05% with a 10-year maturity period ending March 20, 2036Includes an issuer call option after 5 years on March 20, 2031Total of 47 bids received on the NSE Electronic Bidding PlatformFunds will bolster the bank's capital base to support long-term business expansion
👀 கவனிக்க வேண்டியவை
This fundraise strengthens SBI's balance sheet and capital adequacy, which is a positive signal for long-term stability. Investors should maintain their positions as the bank continues to optimize its capital structure at competitive rates.
A B Infrabuild Secures ₹48.68 Crore Railway Project from East Coast Railways
A B Infrabuild Limited has been awarded a significant contract worth approximately ₹48.68 Crore by the East Coast Railways. The project involves the construction of a Road Over Bridge (ROB) between Mandasa and Summadevi stations and technical services for nine level crossings. The scope includes feasibility studies, detailed project reports, and design development for infrastructure improvements. The entire project is scheduled to be completed within a 24-month timeframe.
முக்கிய அம்சங்கள்
Total contract value stands at ₹48,67,75,280.22Project awarded by East Coast Railways, Indian Railways for domestic executionScope includes construction of a Road Over Bridge and technical services for 09 Level CrossingsExecution timeline for the project is set at 24 monthsServices include feasibility studies, DPR, and design development for drainage and rebuilding works
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for the company's order book and revenue visibility over the next two years. Monitor the company's execution efficiency and margin maintenance for this railway infrastructure project.
IDBI Bank Clarifies on Reports of Scrapped Stake Sale; No Official Word from Govt
IDBI Bank has responded to an exchange query regarding news reports suggesting the Government of India (GOI) might scrap its 60.72% stake sale due to low bids. The bank stated it has received no official communication from the GOI regarding the cancellation of the disinvestment process. The bank emphasized that the process is confidential and managed entirely by the Department of Investment and Public Asset Management (DIPAM). Consequently, the bank is unable to confirm or deny the market rumors that recently led to a 13% drop in its stock price.
முக்கிய அம்சங்கள்
IDBI Bank clarifies it has received no communication from the GOI regarding scrapping the disinvestment process.The proposed sale involves a 60.72% stake, comprising 30.48% from the GOI and 30.24% from LIC.The stock experienced a sharp decline of over 13% following rumors of low price bids and potential cancellation.The bank maintains that the disinvestment is a confidential process handled by DIPAM and the bank has no role in negotiations.The bank confirms it has disclosed all price-sensitive information to exchanges as per SEBI regulations.
👀 கவனிக்க வேண்டியவை
Investors should remain cautious as the bank's inability to definitively deny the rumor leaves room for continued volatility. Monitor official statements from DIPAM or the Ministry of Finance for the next steps on the bidding process.
Bikaji Foods Invests ₹40 Crore in Retail Subsidiary for QSR and Cafe Expansion
Bikaji Foods International has infused ₹40 crore into its wholly-owned subsidiary, Bikaji Foods Retail Limited (BFRL), to accelerate its growth in the retail and hospitality sectors. The investment was made by subscribing to 10,52,630 equity shares at a price of ₹380 per share, including a premium of ₹370. BFRL is focused on diversifying the company's reach into Quick Service Restaurants (QSRs), cafes, and food catering services. This move signifies Bikaji's strategic shift towards establishing a direct-to-consumer service footprint beyond its traditional snack manufacturing business.
முக்கிய அம்சங்கள்
Total investment of ₹40 crore in wholly-owned subsidiary Bikaji Foods Retail LimitedSubscription of 10,52,630 equity shares at an aggregate price of ₹380 per shareTarget entity BFRL is focused on QSR, cafes, restaurants, and food catering servicesBFRL reported a turnover of ₹16.71 lakh for the financial year ended March 31, 2025Post-investment, BFRL remains a 100% wholly-owned subsidiary of Bikaji Foods International
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step towards diversification into high-growth QSR and retail segments. Monitor the company's ability to scale these retail outlets effectively, as they typically offer higher margins but require different operational expertise than manufacturing.
ABINFRA Bags ₹66.96 Crore Road Over Bridge Project from East Coast Railways
A B Infrabuild Limited has secured a significant domestic contract from East Coast Railways valued at approximately ₹66.96 crore. The project involves the construction of a Road Over Bridge (ROB) between Icchapuram and Jhadupudi Railway Stations under the Khurdha Road Division. The company is mandated to complete the project within a 24-month timeframe. This win reinforces the company's expertise in railway infrastructure and provides clear revenue visibility for the next two fiscal years.
முக்கிய அம்சங்கள்
Total contract value is ₹66,96,24,916.57 for railway infrastructure worksAwarded by East Coast Railways, Indian Railways, for construction of a Road Over Bridge (ROB)Project execution timeline is set for 24 monthsThe scope includes construction of composite and T-beam girders at specific railway chainages
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for the company's order book and track the execution progress over the next 24 months. Monitor upcoming quarterly results for signs of revenue recognition from this project.
Biocon Receives US FDA Approval for Liraglutide Injection (gVictoza)
Biocon Pharma Limited, a wholly-owned subsidiary of Biocon, has received US FDA approval for its Liraglutide Injection (gVictoza), 18 mg/3 mL. This product is indicated for the treatment of Type 2 Diabetes Mellitus in adults and children aged 10 and above. This approval follows the recent February 24, 2026, approval for gSaxenda, another Liraglutide variant. The move strengthens Biocon's portfolio of vertically integrated, complex drug products in the high-growth US market.
முக்கிய அம்சங்கள்
Received US FDA approval for Liraglutide Injection (gVictoza) 18 mg/3 mL (6 mg/mL) prefilled pens.Approval granted to Biocon Pharma Limited, a 100% subsidiary of Biocon Limited.Follows a previous approval for Liraglutide injection (gSaxenda) received on February 24, 2026.Targeted at the Type 2 Diabetes Mellitus market for patients aged 10 years and older.Strengthens the company's position in vertically integrated, complex generic drug products.
👀 கவனிக்க வேண்டியவை
Investors should monitor the commercial launch and market share gains in the US GLP-1 segment, as this approval enhances Biocon's high-margin complex generics pipeline. The stock may see positive momentum due to the expansion of its diabetes care portfolio.
BIL Vyapar Limited Schedules 6th Committee of Creditors Meeting for March 13, 2026
BIL Vyapar Limited, which is currently undergoing the Corporate Insolvency Resolution Process (CIRP), has announced its sixth Committee of Creditors (CoC) meeting. The meeting is scheduled for March 13, 2026, to discuss matters related to the company's insolvency resolution. This follows the company's transition from its former identity as Binani Industries Limited. Investors should be aware that the outcome of these meetings will significantly dictate the company's future structure and debt obligations.
முக்கிய அம்சங்கள்
The 6th meeting of the Committee of Creditors (CoC) is set for March 13, 2026.The company is operating under the Corporate Insolvency Resolution Process (CIRP).Disclosure is made in compliance with Regulation 30 and Schedule III of SEBI LODR Regulations.BIL Vyapar Limited was formerly known as Binani Industries Limited (NSE: BILVYAPAR).
👀 கவனிக்க வேண்டியவை
Investors should remain highly cautious as equity holders typically face significant value erosion during insolvency proceedings. Monitor subsequent filings for details on any proposed resolution plans or liquidation orders.
SBI Life Receives ₹537.75 Crore Income Tax Demand for FY 2023-24
SBI Life Insurance has received an Income Tax Assessment Order for FY 2023-24 with a total demand of ₹537.75 crore. The demand includes a tax component of ₹441.24 crore and interest of ₹96.51 crore, primarily due to disallowed exemptions and the application of an incorrect tax rate. The company contends that the tax authority erroneously applied a 30% corporate tax rate instead of the applicable rate under section 115B. SBI Life intends to contest this order through an appeal and expects no material impact on its financial operations.
முக்கிய அம்சங்கள்
Total tax demand of ₹537.75 crore received for the assessment of FY 2023-2024.The demand consists of ₹441.24 crore in tax and ₹96.51 crore in interest, with no penalty imposed.Key disputes include disallowed exemptions under sections 10(15) and 10(23AAB) and incorrect tax rate application.Company will file an appeal before the Appellate Authority to contest the assessment order.
👀 கவனிக்க வேண்டியவை
Investors should monitor the outcome of the appeal process as tax litigations are common in the insurance sector but can involve significant sums. No immediate impact on earnings is expected as the company is contesting the demand.
BirlaNu Receives NCLT Approval for Merger of Five Subsidiaries
BirlaNu Limited (formerly HIL Limited) has received formal approval from the NCLT Kolkata for the amalgamation of five subsidiaries into the parent company. The entities include Crestia Polytech and its four step-down subsidiaries: Aditya Poly Industries, Aditya Polytechnic, Prabhu Sainath Polymers, and Topline Industries. Since these are wholly-owned or step-down subsidiaries, no new shares will be issued, and there will be no change in the management or control of BirlaNu. The restructuring is designed to eliminate redundancies and optimize the supply chain and procurement costs.
முக்கிய அம்சங்கள்
NCLT Kolkata sanctioned the Scheme of Amalgamation via an order dated March 10, 2026.Five subsidiaries, including Crestia Polytech and its step-down units, will be dissolved without winding up.Zero new shares will be issued as the transferor companies are 100% directly or indirectly owned by BirlaNu.The merger aims to reduce operational expenses and raw material costs through resource pooling.BirlaNu will maintain a positive net worth post-merger with no impact on creditor rights.
👀 கவனிக்க வேண்டியவை
This is a positive internal restructuring that should lead to better operational margins through cost synergies. Investors should monitor the company's upcoming quarterly results for signs of improved administrative and supply chain efficiency.
Hester Biosciences to Divest 43.81% Stake in Texas Lifesciences for INR 92 Million
Hester Biosciences has announced the divestment of a 43.81% equity stake in its subsidiary, Texas Lifesciences Private Limited (TLPL), for a total consideration of INR 92 million. Following the sale to Ticop Life Private Limited, Hester will retain an 11% stake, and TLPL will cease to be a subsidiary. TLPL reported a turnover of INR 285.89 million in FY 2024-25, though over 97% of its sales were internal to Hester. This move allows Hester to unlock capital while maintaining a strategic business relationship with the entity.
முக்கிய அம்சங்கள்
Divesting 43.81% stake out of 54.81% total holding in Texas Lifesciences Private Limited.Total aggregate consideration for the sale is INR 92 million.TLPL's FY 2024-25 turnover was INR 285.89 million with a net worth of INR 134.17 million.Hester will maintain an 11% equity stake and continue business operations with TLPL.The transaction is expected to be completed within three months from March 5, 2026.
👀 கவனிக்க வேண்டியவை
Investors should watch for the impact on consolidated margins since TLPL's internal sales were previously eliminated, and monitor the utilization of the INR 92 million proceeds.
Panacea Biotec Wins Major Tax Case; ₹329.49 Crore Tax Demand Cancelled by ITAT
Panacea Biotec has received a favorable ruling from the Income Tax Appellate Tribunal (ITAT) regarding long-standing tax disputes for Assessment Years 2005-06 to 2012-13. The ITAT dismissed eight appeals by the tax department and allowed two appeals by the company, effectively quashing the previous assessment orders. This decision results in the cancellation of a massive tax demand totaling ₹329.49 Crore. The ruling removes a significant contingent liability and potential penalty exposure from the company's financial records.
முக்கிய அம்சங்கள்
ITAT quashed assessment orders for eight Assessment Years spanning 2005-06 to 2012-13.Cancellation of a total tax demand amounting to ₹329.49 Crore previously raised by the Assessing Officer.Deletion of all expense disallowances that were under litigation since Financial Year 2015-16.The ruling dismisses eight appeals filed by the Deputy Commissioner of Income Tax (DCIT) against the company.
👀 கவனிக்க வேண்டியவை
This is a significant positive development that strengthens the balance sheet by removing a large liability; investors should monitor if the tax department files a further appeal in the High Court.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
